Velcadito: Low dose of bortezomib with melphalan and prednisone for >= 75-year-olds newly diagnosed with multiple myeloma
Ernesto Perez-Persona,Itziar Oiartzabal-Ormategui, Susana Herraez, Carmen Menchaca, Laida Cuevas-Palomares, Ana Santamaria-Lopez,Rosana Diez-Angulo, Diego Robles-Castro,Carlos de Miguel-Sanchez,Miren Gabilondo-Jalon, Carlos Pison-Herrero, Ariane Unamunzaga-Cilaurren, Ana Vega Gonzalez-Vinaspre, Laura Salcedo-Cuesta,Arantza Mendizabal-Abad,Jose Maria Guinea de Castro European journal of haematology（2022）
关键词
bortezomib-melphalan-prednisone, dose intensity reduction, elderly, multiple myeloma
AI 理解论文
溯源树
样例
